EUVIMEDEUVIMED entdecken
Open Access

Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine

Kelly Crane, K R Seetharam Bhat, P Grivas, Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Joseph M Jacob, Hanan Goldberg, Rebecca Sager, Jeffery S Ross

Oncotarget · 19.08.2026 · 17 (1) · 381-387

DOI: 10.18632/oncotarget.28912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 19.08.2026. Verfasst von Kelly Crane und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Mutation, Urogenital Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)MutationUrogenital NeoplasmsHumansMalePrecision MedicineFemaleAgedMiddle AgedAged, 80 and overAdultIncidenceBiomarkers, TumorUrinary Bladder NeoplasmsDNA Mutational AnalysisMicrosatellite Instability

Stichwörter der Autor:innen

KRAS mutationemerging targetgenitourinary malignancyprecision medicine

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanBiomarkers, Tumor

Zitieren

APA

Crane, K., Bhat, K. R. S., Grivas, P., Necchi, A., Bratslavsky, G., Shapiro, O., Jacob, J. M., Goldberg, H., Sager, R., & Ross, J. S. (2026). Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine. Oncotarget, 17(1), 381-387. https://doi.org/10.18632/oncotarget.28912

Vancouver

Crane K, Bhat KRS, Grivas P, Necchi A, Bratslavsky G, Shapiro O, et al. Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine. Oncotarget. 2026;17(1):381-387. doi:10.18632/oncotarget.28912

BibTeX
@article{Crane2026,
  author = {Crane, Kelly and Bhat, K R Seetharam and Grivas, P and Necchi, Andrea and Bratslavsky, Gennady and Shapiro, Oleg and Jacob, Joseph M and Goldberg, Hanan and Sager, Rebecca and Ross, Jeffery S},
  title = {Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {381--387},
  doi = {10.18632/oncotarget.28912}
}
Kostenlos starten →